SPINEGUARD |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.235 EUR | -2.49% |
|
-4.47% | +17.74% |
| Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SpineGuard designs, produces, and sells medical devices used for securing spinal surgery patients. The group offers PediGuard, an instrument for drilling and secure insertion of pedicular screws in the vertebrae.
The United States account for 67.6% of net sales.
Calendar
2024-06-04
- Annual General Meeting - First Call
| 1st Jan change | Capi. | |
|---|---|---|
| +17.74% | 12.2M | |
| +71.87% | 12.28B | |
| -19.76% | 7.81B | |
| +15.96% | 7.19B | |
| -6.42% | 5.23B | |
| +4.54% | 4.94B | |
| +18.62% | 4.24B | |
| -25.36% | 3.97B | |
| -40.48% | 2.24B | |
| -3.47% | 1.92B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard : Shares Surge 45% on US FDA Approval For Commercial Release of Software
